September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...

September 25, 2007 - The Medicines Company announced that the FDA has accepted its supplemental new drug application (sNDA) for a modified dosing regimen of Angiomax (bivalirudin) for the treatment of acute coronary syndromes (ACS), specifically in patients with unstable angina or non-segment elevation myocardial infarction (NSTEMI), which could replace heparin in patients undergoing angioplasty.

September 21, 2007-The CYPHER Sirolimus-eluting Coronary Stent reduced by more than half the rate of major adverse ...

September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.

September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.

September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) ...

September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.